Mesoblast (MESO) Interest Coverage Ratio (2015 - 2023)
Mesoblast recorded quarterly Interest Coverage Ratio of 5.58 in Q2 2023, up 23.53% quarter-over-quarter from 7.3 in Q1 2023, and down 4.08% year-over-year from 5.82 in Q2 2022.
Mesoblast's Interest Coverage Ratio history runs 9 years deep, the most recent figure standing at 5.58 for Q2 2023.
- In Q2 2023, Interest Coverage Ratio fell 4.08% year-over-year to 5.58; the TTM figure through Jun 2023 stood at 49.72 (up 98.95% YoY), while the FY2025 annual figure was 2.7, up 3.92% from the prior year.
- Interest Coverage Ratio came in at 5.58 for Q2 2023 at Mesoblast, up from 7.3 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 2752.44 in Q2 2021 to a low of 3519.93 in Q1 2020.
- A 5-year average of 15.37 and a median of 2.03 in 2020 frame the typical range for Interest Coverage Ratio.
- On a YoY basis, Interest Coverage Ratio climbed as much as 15239.21% in 2020 and fell as far as 2422.17% in 2020.
- Mesoblast's Interest Coverage Ratio stood at 169.2 in 2019, then surged by 101.15% to 1.95 in 2020, then soared by 12227.25% to 240.81 in 2021, then declined by 29.72% to 169.25 in 2022, then plunged by 103.3% to 5.58 in 2023.
- According to Business Quant data, Interest Coverage Ratio over the past three periods registered 5.58, 7.3, and 169.25 for Q2 2023, Q1 2023, and Q4 2022 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -129.79 |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 3.58 |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -258.33 |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 11.50 |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 49.84 |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 3.88 |
| 10 | Mesoblast | 23.40 Bn | 23.27 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | -5.58 |
| Mar 31, 2023 | -7.30 |
| Dec 31, 2022 | 169.25 |
| Sep 30, 2022 | -63.45 |
| Jun 30, 2022 | -5.37 |
| Mar 31, 2022 | -1.09 |
| Dec 31, 2021 | 240.81 |
| Sep 30, 2021 | 246.51 |
| Jun 30, 2021 | 2,752.44 |
| Mar 31, 2021 | -201.33 |
| Dec 31, 2020 | 1.95 |
| Sep 30, 2020 | -2.98 |
| Jun 30, 2020 | 322.26 |
| Mar 31, 2020 | -3,519.93 |
| Dec 31, 2019 | -169.20 |
| Sep 30, 2019 | 103.83 |
| Jun 30, 2019 | 2.10 |
| Mar 31, 2019 | -139.56 |
| Dec 31, 2018 | -213.43 |
| Sep 30, 2018 | 222.94 |
| Jun 30, 2018 | -12.17 |
| Mar 31, 2018 | 1,833.57 |
| Mar 31, 2017 | -8.70 |
| Dec 31, 2016 | 8.28 |
| Sep 30, 2016 | 7.88 |
| Mar 31, 2016 | -3.27 |
| Dec 31, 2015 | 12.02 |